CSL Limited (ASX:CSL)
Pharmaceuticals, Biotechnology & Life Sciences
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
CSL Limited (ASX:CSL) share price
CSL Limited (ASX:CSL) share price news
ASX tech shares
Is this the next REA Group (ASX:REA)?
There really isn’t a “secret sauce” behind these stories – it is purely a matter of scouring the market for companies displaying solid fundamentals (which we define as our “Golden Rules”), and then allowing these businesses to compound both earnings and cash flows over many, many years.
September 14, 2023
ASX Growth Shares
Cochlear Ltd (ASX:COH) share price pops: our Cochlear thesis
The Cochlear Limited (ASX: COH) share price bounced dramatically higher this week following a bumper report. But is the Cochlear share price looking a little expensive? Stock Doctor’s Daniel Ortisi weighs in.
August 17, 2023
ASX Growth Shares
CSL (ASX:CSL) share price climbs on mixed FY23 profit, FY24 guidance
The CSL Ltd (ASX:CSL) share price is up more than 3% after reporting its FY23 result and guiding more growth for FY24.
August 15, 2023
ASX Growth Shares
Why the ResMed (ASX:RMD) share price is down 11% today
ResMed CDI (ASX: RMD) shares are trading down about -11% in early trade to ~$30 per share after its 4Q23 result came in below consensus expectations.
August 4, 2023
ASX Share Ideas
Under $270, is the CSL Limited (ASX:CSL) share price a bargain?
The CSL Limited (ASX: CSL) share price has fallen below $270 after an earnings outlook statement disappointed the market.
July 25, 2023
ASX Growth Shares
DON’T flee the NASDAQ! Tesla pops, Zip flops, guess my PE, what is long term? And best sectors to buy in 2023
On The Australian Investors Podcast this week, Owen Rask and Drew Meredith reflect on results from companies like BHP Group (ASX: BHP), Tesla Inc (NASDAQ: TSLA) and how the NASDAQ 100 (NDQ) has performed.
July 22, 2023
ASX Growth Shares
CSL (ASX:CSL) share price in focus on currency profit hit, FY24 guidance
The CSL Limited (ASX:CSL) share price is in focus as the healthcare giant gave investors a profit update for FY23.
June 14, 2023
ASX Growth Shares
Tim Lincoln’s PhD-level quant rules, why numbers don’t lie and will A.I. take our investing edge?
Tim Lincoln is the co-founder of Lincoln Indicators. Tim Lincoln recently sat down with Owen Rask on The Australian Investors Podcast to talk about the origins of the Stock Doctor ‘financial health’ model, which is based on PhD research.
May 24, 2023
ASX Growth Shares
Why the Resmed (ASX: RMD) share price is charging higher today
The Resmed CDI (ASX:RMD) share price bounced 6.5% higher today following the release of its Q3 results. Resmed and CSL Limited (ASX:CSL) seem good value relative to Cochlear Limited (ASX:COH).
May 1, 2023